Participation History
1st
2nd
3rd
Xinbaotang was founded in the 34th year of the Guangxu reign (1908 AD). It is a "Chinese time-honored brand" enterprise with a history of 116 years and a profound brand culture. It is a provincial-level inheritor unit of the national intangible cultural heritage "Xinhui Chenpi Processing Technology" and a provincial-level demonstration base for the production protection of intangible cultural heritage. It is also a "Guangchenpi Ecological Planting Demonstration Base and Origin Processing Technology Demonstration" approved by the Ministry of Science and Technology of China. It is a leading enterprise in the Science and Technology Innovation Zone of Xinhui Chenpi National Modern Agricultural Industrial Park, a national high-tech enterprise, and a key agricultural leading enterprise in Guangdong Province.
Participation History
1st
2nd
3rd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. has systematically constructed the Collateral Disease Theory, built a new development pattern of “Integrating Theory, Clinical Treatment, R&D, Industrialization, and Education”. Yiling undertaken more than 60 research programs including the China National “973 Plan” programs, National“863 Plan” programs. Yiling has developed more than 10 patented new drugs. More than 800 patents have been obtained, and six national awards have been gained, including the First Prize of the National Science and Technology Progress Award.Yiling is a key national hi-tech enterprise with numerous honorary titles, such as Top 10 China TCM Company, Top 20 China Listed Pharmaceutical Company, Top 100 Most Valuable Chinese Brand, “National Advanced Grassroots Party Organization” by the CPC Central Committee, etc.
Participation History
1st
2nd
3rd
Yabao Pharmaceutical Group Co., Ltd. established in 1978, it went public on the Shanghai Stock Exchange in 2002. Yabao Pharmaceutical adheres to the strategic approach of "Pediatrics First, Adult Medicines Supplement, Investment & Innovation." Guided by clinical demands, led by internationalization, and driven by talent and technology, the company focuses on pediatrics. It has implemented a comprehensive layout in various areas such as innovative drugs, complex generic drugs, Traditional Chinese Medicine, and comprehensive health products. The company has established a national-level enterprise technology center, post-doctoral research stations, and academician workstations. It possesses over 1000 intellectual property rights, including authorized patents, registered trademarks, and copyrights. The company has established nine major production bases and three R&D bases，and multiple production lines have been certified by developed countries such as the United States, Germany, and Japan.
Participation History
2nd
3rd
慕思品牌自 2004 年创立，是软体家具行业领先的集研发、设计、生产、销售和服务于一体的健康睡眠系统整体解决方案服务商。截止目前，慕思线下睡眠体验馆已覆盖全球 14 个国家，拥有超过 5700 家线下门店。公司秉承“让人们睡得更好”的企业使命，长期致力人体健康睡眠研究，积极整合全球优质睡眠资源，推动技术创新与技术转化，不断为用户提供优质的健康睡眠体验。